Stereotaxis (NYSEAMERICAN:STXS), Inc. develops and commercializes robotic magnetic navigation systems designed to advance the treatment of cardiac arrhythmias. By harnessing precise magnetic fields, the company’s platforms allow electrophysiologists to navigate specially designed catheters through the vascular system with submillimeter accuracy. This remote navigation technology aims to reduce procedure times, improve safety, and enhance clinical outcomes for patients undergoing complex catheter‐based ablations.
The company’s flagship offerings include the Niobe® and Genesis RMN® (Remote Magnetic Navigation) systems, which integrate seamlessly with existing imaging and mapping equipment in catheterization laboratories. These systems are supported by proprietary software that provides real‐time visualization of catheter position and automated control algorithms to assist in lesion delivery. Ancillary products, such as navigation catheters, patches, and system upgrades, complement its core robotic platforms and support ongoing procedural innovations.
Since its founding in 1996 and headquarters in St. Louis, Missouri, Stereotaxis has expanded its reach to major medical centers across North America, Europe and the Asia‐Pacific region. Collaborative research agreements with leading cardiac institutes have fostered continuous product enhancements and clinical validation studies. The company leverages a global service network to provide installation, training, and technical support, ensuring that clinical teams can fully utilize the unique capabilities of its robotic systems.
Guided by a seasoned management team with deep expertise in medical device development, regulatory affairs, and cardiovascular electrophysiology, Stereotaxis pursues strategic partnerships to broaden its technology applications. The Board of Directors and executive leadership work closely with key opinion leaders in the arrhythmia community to drive adoption, refine system performance, and explore future expansions into adjacent interventional markets.
